Practical Considerations for the Management of Children With Moderate-to-severe Atopic Dermatitis - Expert Interview

• Examine the challenges faced by dermatologists when managing moderate-to-severe atopic dermatitis in children (<12 years)
• Explore the relevance of targeting type 2 inflammation and the implications for disease course modification in childhood
• Review emerging data on treatment options and practical management of children with moderate-to-severe atopic dermatitis

In the ADVENT symposium at the 2023 World Congress of Dermatology, entitled “Atopic Dermatitis (AD) in Children: Early Intervention Can Reduce Long-term Disease Impact” experts Amy Paller, MD (Northwestern University, USA), Mark Koh, MD (KK Women’s & Children’s Hospital, Singapore), Stephan Weidinger, MD, PhD (Christian-Albrecht University, Kiel, Germany) and Elaine Siegfried, MD (Saint Louis University School of Medicine, USA), delved into the challenges and advancements in the management of moderate-to-severe atopic dermatitis in pediatric patients. The presentations emphasized the significance of targeting type 2 inflammation, explored implications for disease course modification during childhood, and provided insights into emerging treatment options and practical management strategies for children with moderate-to-severe atopic dermatitis.